Chester County News and Community Website
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) will hold a live webcast aimed at providing patients, caregivers, and families with updates on its clinical trials and future plans. The virtual …
Annovis Bio to Host Patient-Centered Webcast on Key Clinical Developments Read More MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has made strides in the fight against neurodegenerative diseases with the filing of three new patents. These cover novel combination therapies involving their …
Annovis Bio Files Patents for Innovative Therapies in Neurodegenerative Disease Treatment Read More MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has received approval from the U.S. Food and Drug Administration (FDA) to transition to a new solid form of buntanetap in future …
Annovis Bio Gains FDA Approval for New Form of Neurodegenerative Drug Read More MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) recently disclosed the encouraging results of its Phase III clinical trial related to Parkinson’s disease treatment. The experimental drug, buntanetap, has shown …
Annovis Bio’s Breakthrough in Parkinson’s Treatment: New Drug Buntanetap Shows Promise Read More
DOYLESTOWN, PA — Kannalife Sciences, Inc. has received a $1.49 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). This funding will support preclinical research on Kannalife’s …
Kannalife Sciences Secures $1.49 Million Grant for Parkinson’s Research Read More
WEST BRANDYWINE, PA — In an inspiring show of community spirit and commitment, Freedom Village at Brandywine marked World Parkinson’s Day by joining the “Pump it for Parkinson’s” initiative led …
Freedom Village Steps Up for Parkinson’s Awareness with Record-Breaking Initiative Read More BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS) has recently announced the completion of the last patient visit in its phase III study of buntanetap, a leading candidate for treating …
Annovis Bio Finalizes Phase III Study of Buntanetap in Early Parkinson’s Treatment, Awaits Topline Data Read More BERWYN, PA — In a recent breakthrough, Annovis Bio (NYSE: ANVS), a biopharmaceutical company, has successfully performed measurements of critical biomarkers in the plasma of Parkinson’s disease patients. Utilizing buntanetap, …
Annovis Bio’s Buntanetap Demonstrates Potential to Lower Key Biomarkers in Parkinson’s Disease Read More
PAOLI, PA — According to the Parkinson’s Foundation, nearly 1 million people in the United States are living with Parkinson’s Disease (PD), and that number is expected to rise to …
SageLife Delivering Results for Individuals with Parkinson’s and Movement Disorders Read More